April 13, 2023

Vadim Klyushnichenko - VP Pharmaceutical Development -Scripps Research

In this episode of the Life Science Success Podcast my guest is Vadim Klyushnichenko, Ph.D, Vadim is the VP Pharmaceutical Development at Scripps Research. He has over 25 years of progressive experience in Global Bio/Pharmaceutical...

Show Notes
Guest Profile

Introduction

02:35 Tell listeners a little bit about himself.

06:42 Tell us more specifically about your current role and responsibilities at Scripps. What is it that, you do on a daily basis?

10:58 What does the process look like as you're going from, essentially the lab that you're in at Scripps to a CDMO, what does that process look like?

15:05 What's your work? Previously at places like Catalent and Pfizer and all these other, larger scale companies, how is working for Scripps or caliber the same?

21:27 So in your role today, what are some of the biggest challenges that you face?

25:04 Where do you see the biggest opportunities in your current role then?

25:57 There are some questions that I like to ask every guest.

-What Inspires you?

26:44 -What concerns you?

28:20 -What excites you?

Please check out our Life Science Success Resources. You will find tools that will support growing companies and books for authors I have interviewed.

Vadim Klyushnichenko

Dr.Klyushnichenko, VP Pharmaceutical Development and Quality at Calibr, the division of the Scripps Research Institut, La Jolla, CA Dr.Klyushnichenko has over 20 years of experience in Bio/Pharmaceutical Development and Manufacturing. His Drug Development experience includes the production of small molecules and proteins as well as their formulation in micro- and nano-particles, controlled-release systems for oral, injectable, implantable and pulmonary delivery. Currently, Vadim is responsible for the development of small molecules, biologics, gene and cell therapy products as well as their supply chain, which involves multiple CDMOs in the US, EU, India and China. Vadim has developed his growing managerial and scientific responsibilities working as VP of Drug Development at Paragon BioServices, Terapio Corporation, and Coldstream Laboratories Inc., Lab Head/Principal Scientist at Wyeth/Pfizer, Sr.Scientist at Baxter, Altus and Aventis. Vadim has received his B.S. in Physics from Moscow Institute of Physics and Technology (FizTech), Ph.D. in Chemistry from the Russian Academy of Sciences, and continued his postdoctoral research in Germany and Canada. He has received a Certificate in Management and Business Administration from Harvard University.